Mount Carmel Health System Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2013
NCT02937506
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Marvin McCreary, MD | Mount Carmel Health System

Active Ingredients

Drugs in Phase 4 Trials (3)

fentanyl (Innovar) (1 trial)

midazolam (versed) (1 trial)

propofol (diprivan) (1 trial)

Drugs in Phase 2 Trials (2)

resveratrol (1 trial)

vitamin d3 (1 trial)

Drugs in Other Trials (2)

coffee (1 trial)

oxycodone (oxycontin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colonic Neoplasms (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 7